Efficacy and safety of anelazole diphtherapy and furazolidone-based bismuth quadruphtherapy for eradication of Helicobacter pylori: a prospective, multicentre, open-label, randomised controlled clinical study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 284c32cbef282ae600b61e98cce0a186a46fa388
First added on: Apr 08, 2025